These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16778720)

  • 1. Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.
    Auret K; Roger Goucke C; Ilett KF; Page-Sharp M; Boyd F; Oh TE
    Ther Drug Monit; 2006 Jun; 28(3):359-66. PubMed ID: 16778720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?
    George R; Haywood A; Good P; Hennig S; Khan S; Norris R; Hardy J
    Clin Ther; 2017 Sep; 39(9):1840-1848. PubMed ID: 28827023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
    Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
    J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered plasma and brain disposition and pharmacodynamics of methadone in abstinent rats.
    Garrido MJ; Valle M; Calvo R; Trocóniz IF
    J Pharmacol Exp Ther; 1999 Jan; 288(1):179-87. PubMed ID: 9862769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
    Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
    Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone.
    Benmebarek M; Devaud C; Gex-Fabry M; Powell Golay K; Brogli C; Baumann P; Gravier B; Eap CB
    Clin Pharmacol Ther; 2004 Jul; 76(1):55-63. PubMed ID: 15229464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slow metabolism and long half life of methadone in a patient with lung cancer and cirrhosis.
    Beauverie P; Furlan V; Edel YA
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():50-2. PubMed ID: 11965098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
    Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
    J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methadone.
    Lugo RA; Satterfield KL; Kern SE
    J Pain Palliat Care Pharmacother; 2005; 19(4):13-24. PubMed ID: 16431829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone.
    Chhabra S; Bull J
    Am J Hosp Palliat Care; 2008; 25(2):146-50. PubMed ID: 18445864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update of the clinical issues regarding methadone (Dolophine) therapy in pain management.
    Linderbeck LR
    AACN Adv Crit Care; 2008; 19(3):253-7. PubMed ID: 18670197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methadone--pharmacokinetics and pharmacodynamics of an opiate].
    Jage J
    Anaesthesist; 1989 Apr; 38(4):159-66. PubMed ID: 2567128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
    Dyer KR; Foster DJ; White JM; Somogyi AA; Menelaou A; Bochner F
    Clin Pharmacol Ther; 1999 Jun; 65(6):685-94. PubMed ID: 10391674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of methadone absorption after topical administration to hospice patients.
    Sylvester RK; Schauer C; Thomas J; Steen P; Weisenberger A
    J Pain Symptom Manage; 2011 May; 41(5):828-35. PubMed ID: 21330095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (S)-(+)-methadone is more immunosuppressive than the potent analgesic (R)-(--)-methadone.
    Hutchinson MR; Somogyi AA
    Int Immunopharmacol; 2004 Nov; 4(12):1525-30. PubMed ID: 15351321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone isomers and their role in pain management.
    Prommer EE
    Am J Hosp Palliat Care; 2009; 26(2):149-50; author reply 151. PubMed ID: 19282393
    [No Abstract]   [Full Text] [Related]  

  • 20. Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.
    Fredheim OM; Borchgrevink PC; Klepstad P; Kaasa S; Dale O
    Eur J Pain; 2007 Aug; 11(6):599-604. PubMed ID: 17113329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.